SFX by Ex Libris Inc.

Title:	Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations
Source:	Nature Medicine [1078-8956] Schubert, Desirée yr:2014

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Lo, B. "Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy." Science 349.6246 (2015): 436-440.
description	2.	Kuehn, Hye S. "Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4." Science 345.6204 (2014): 1623-7.
description	3.	Casanova, J. "Immunology. Autoimmunity by haploinsufficiency." Science 345.6204 (2014): 1560-1.
description	4.	Carbone, F. "Regulatory T cell proliferative potential is impaired in human autoimmune disease." Nature medicine 20.1 (2013): 69-74.
description	5.	Regner, M. "Autoimmunity through infection or immunization?" Nature immunology 2.3 (2001): 185-8.
description	6.	Qureshi, Omar S. "Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell Extrinsic Function of CTLA-4." Science 332.6029 (2011): 600-3.
description	7.	Delves, Peter J. Roitt's essential immunology. 2011.
description	8.	De Jonghe, P. "Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder?" Brain 125.Pt 6 (2002): 1320-5.
description	9.	Godfrey, Dale I I. "CD1d antigen presentation: treats for NKT cells." Nature immunology 6.8 (2005): 754-6.
description	10.	Zhou, P. "In vivo discovery of immunotherapy targets in the tumour microenvironment." Nature 506.7486 (2014): 52-57.
description	11.	Lopez Herrera, G. "Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity." American journal of human genetics 90.6 (2012): 986-1001.
description	12.	Notarangelo, Luigi D. "Primary immunodeficiencies (PIDs) presenting with cytopenias." Hematology 2009.1 (2009): 139-143.
description	13.	Notarangelo, L. "Primary immunodeficiency diseases: an update." The journal of allergy and clinical immunology 114.3 (2004): 677-87.
description	14.	Rawlings, David J. "The Role of PTPN22 Risk Variant in the Development of Autoimmunity: Finding Common Ground between Mouse and Human." The journal of immunology 194.7 (2015): 2977-2984.
description	15.	Einarsdottir, E. "The CTLA4 region as a general autoimmunity factor: An extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease." European Journal of Human Genetics : EJHG 11.1 (2003): 81-84.
description	16.	Carapetis, Jonathan R. "Acute rheumatic fever and rheumatic heart disease." Nature Reviews Disease Primers 2.1 (2016): 15085-15085.
description	17.	Leong, Jeffrey W. "Pre-activation with IL-12, IL-15, and IL-18 induces CD25 and a functional high affinity IL-2 receptor on human cytokine-induced memory-like NK cells." Biology of blood and marrow transplantation 20.4 (2014): 463-473.
description	18.	Williams, D. "High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3." Nature Immunology 15.2 (2013): 152-160.
description	19.	Sakaguchi, S. "The plasticity and stability of regulatory T cells." Nature reviews. Immunology 13.6 (2013): 461-467.
description	20.	Cheng, G. "IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells." The journal of immunology 189.4 (2012): 1780-1791.